Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCMC Markets Regulatory News (CMCX)

Share Price Information for CMC Markets (CMCX)

Share Price is delayed by 15 minutes
Get Live Data
455.00    -4.50 (-0.98%)
Bid:
454.50
Ask:
455.50
Spread: 1.00 (0.22%)
Market Cap: £1.23b
CMCX Live PriceLast checked at - London Stock Exchange

Intraday CMC Markets Share Chart

Board and Directorate Changes

5 Jun 2025 07:05

RNS Number : 5494L
CMC Markets Plc
05 June 2025
 

05 June 2025

CMC Markets plc ("CMC") 

Board and Directorate Changes

CMC Markets plc (LON:CMCX) today announces several changes to its Board of Directors and senior leadership team.

· David Fineberg, currently Deputy Chief Executive Officer and Board Director, will not stand for re-election at the 2025 Annual General Meeting ("AGM"). He will transition into the newly created role of Global Head of Strategic Partnerships, with a focus on strengthening key institutional relationships and accelerating growth through partnerships such as Revolut and StrikeX.

· Matthew Lewis, currently Head of ANZ and Board Director, will also step down from the Board at the 2025 AGM. He will focus fully on expanding the Group's footprint across the ANZ region, particularly in stockbroking and digital asset services.

· The Board is pleased to confirm the appointment of Laurence Booth to the Board as an Executive Director, effective 5 June 2025. Laurence will continue in his role as Global Head of Capital Markets, bringing extensive global execution and capital markets expertise to the Board.1

· As previously announced, James Richards, Non-Executive Chairman, will step down at the 2025 AGM. James has served on the Board since 2015 and as Chairman since 2018. The Board is pleased to confirm that Paul Wainscott, currently Senior Independent Director, will succeed James as Chairman following the AGM.

The Board would like to express its sincere thanks to David Fineberg and Matthew Lewis for their Board service and looks forward to their continued contributions in their respective leadership roles. The Board also extends its deep gratitude to James Richards for his dedication and leadership over the past decade.

1 There is no other information to be disclosed under UK Listing Rule 6.4.8R (1) to (6) in relation to Laurence Booth.

END

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFIFSIRIIEIIE
Date   Source Headline
19th Nov 20207:00 amRNSInterim results
10th Nov 202010:06 amRNSDirector/PDMR Shareholding
26th Oct 20207:00 amRNSAppointment of Joint Corporate Broker
23rd Oct 20208:44 amRNSCMC welcomes ASIC consultation paper outcome
8th Oct 20207:00 amRNSTrading Update
6th Oct 20202:51 pmRNSDirector/PDMR Shareholding
22nd Sep 20204:45 pmRNSDirector/PDMR Shareholding
17th Sep 20204:19 pmRNSDirector/PDMR Shareholding
14th Sep 20209:15 amRNSIssue of Equity
9th Sep 20204:02 pmRNSDirector/PDMR Shareholding
9th Sep 20203:58 pmRNSHolding(s) in Company
3rd Sep 20207:00 amRNSTrading Update
2nd Sep 202010:40 amRNSCompliance with Listing Rule 9.2.6E
10th Aug 202011:34 amRNSDirector/PDMR Shareholding
30th Jul 20204:08 pmRNSRESULTS OF 2020 ANNUAL GENERAL MEETING
30th Jul 20201:58 pmRNSDirector/PDMR Shareholding
20th Jul 20202:14 pmRNSHolding(s) in Company
13th Jul 20207:00 amRNSAppointment of Chief Technology Officer
8th Jul 20203:41 pmRNSDirector/PDMR Shareholding
3rd Jul 20207:00 amRNSQ1 2021 Trading Update
11th Jun 20207:00 amRNSFinal results
8th Jun 20202:59 pmRNSDirector/PDMR Shareholding
7th May 20204:44 pmRNSDirector/PDMR Shareholding
8th Apr 20208:35 amRNSDirector/PDMR Shareholding
3rd Apr 20207:00 amRNSFY 2020 Pre-Close Trading Update
23rd Mar 202012:08 pmRNSSecond Price Monitoring Extn
23rd Mar 202012:02 pmRNSPrice Monitoring Extension
20th Mar 20207:00 amRNSCOVID-19 and Trading Update
12th Mar 20204:37 pmRNSPrice Monitoring Extension
9th Mar 20202:16 pmRNSDirector/PDMR Shareholding
3rd Mar 20207:00 amRNSTrading Update
7th Feb 202010:56 amRNSDirector/PDMR Shareholding
23rd Jan 20207:00 amRNSQ3 Trading Update
8th Jan 20203:20 pmRNSDirector/PDMR Shareholding
9th Dec 20192:29 pmRNSDirector/PDMR Shareholding
21st Nov 20197:00 amRNSInterim Results
7th Nov 20193:54 pmRNSDirector/PDMR Shareholding
31st Oct 20197:00 amRNSBoard Changes
15th Oct 201912:02 pmRNSPrice Monitoring Extension
9th Oct 20193:54 pmRNSDirector/PDMR Shareholding
3rd Oct 20197:00 amRNSH1 2020 Pre-Close Trading Update
17th Sep 20193:36 pmRNSDirector/PDMR Shareholding
17th Sep 20193:22 pmRNSIssue of Equity
13th Sep 20194:27 pmRNSDirector/PDMR Shareholding
9th Sep 20193:06 pmRNSDirector Declaration
30th Aug 201912:02 pmRNSNotification of transaction by PDMR's PCA
30th Aug 201911:49 amRNSDirector/PDMR Shareholding
22nd Aug 201911:52 amRNSResponse to ASIC consultation paper
9th Aug 201912:25 pmRNSHolding(s) in Company
6th Aug 20194:19 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.